On April 1, 2024, Stavros G. Vizirgianakis announced that he desires to engage with management and the board of directors of Apyx Medical Corporation to discuss the numerous issues facing the Company and in the near future and would like to work with management and the board of directors of the Company to conduct a strategic review of all commercial activities and to gain deeper insight into the financial and operational challenges that lie ahead so that any necessary changes and meaningful actions can be implemented to address shareholder concerns, restore confidence and drive value creation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | -9.64% | +6.38% | -42.75% |
05-09 | Transcript : Apyx Medical Corporation, Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.75% | 51.97M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+24.51% | 32.3B | |
+3.43% | 26.53B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- APYX Stock
- News Apyx Medical Corporation
- Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation